Deep TMS

July 14, 2016

TMS for Depression during Pregnancy and Postpartum

By Suzanne Kerns, M.D. Women who suffer from depression during pregnancy or in the postpartum period might not seek treatment if they assume medication is the only treatment option available to them. Although concerns about taking medication while pregnant or breastfeeding are understandable, untreated depression can also be very dangerous. Women who want to avoid or limit the use of antidepressants may consider Transcranial Magnetic Stimulation (TMS) as a safe and effective treatment option. Approved by the FDA in 2008 for treating depression, TMS works by delivering electromagnetic pulses to specific areas of the brain that regulate mood. A standard […]
May 5, 2016

TMS versus ECT

By Joshua Bess, M.D. The first line of treatment for patients suffering from anxiety and depression is typically antidepressant medication and psychotherapy. If these treatments have not been as effective as hoped, it may be time to consider brain stimulation therapy. There are two kinds of brain stimulation technologies that are FDA-approved for depression. One is Transcranial Magnetic Stimulation (TMS) and the other is Electroconvulsive Therapy (ECT). TMS and ECT are safe and effective treatment options for adults who have tried medication and psychotherapy for anxiety or depression without seeing good results. Both TMS and ECT work by stimulating specific […]
September 2, 2014

Brainsway Deep TMS

We have added a new TMS device at our Cherry Hill Office:  Brainsway Deep TMS.  Deep TMS (dTMS) is a new technology that produces significantly deeper cortical stimulation.  Brainsway Deep TMS is approved by the FDA for Major Depressive Disorder.  The FDA indication is based on a 16-week double-blind, placebo-controlled multi-center study, which enrolled over 200 subjects, showing a profound decline in the Hamilton Depression Rating Scale (HDRS-21), a significant remission rate of 32.6% and an even higher response rate in treatment resistant patients.  Brainsway Deep TMS is currently being studied in over 60 clinical trials at leading institutions worldwide.  Approved clinical indications in […]